Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
56
days
Metabolism of new drug modalities research advances – 2025 year in review
Authors
Bin Ma; Lionel Cheruzel; Sungjoon Cho; Simon Hauri; Xiuli Li; Joyce Liu; Karoline Rehm; Herana Kamal Seneviratne; Hyeonglim Seo; Rachel Liuqing Shi; Lloyd Wei Tat Tang; Pengcheng Wang; Yue-Ting Wang; Caroline Wei; Guo Zhong; S. Cyrus KhojastehShow moreShow less
Affiliations
1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc; 2. Roche Pharma Research and Early Development, Pharmaceutical Sciences; 3. Department of Pharmaceutical Sciences, China Innovation Center of Roche; 4. Department of Chemistry and Biochemistry, University of Maryland; 5. Department of Biochemical and Cellular Pharmacology, Genentech, Inc; 6. Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc; 7. Pharmacokinetic Sciences Biomedical Research; 8. Quantitative, Translational, & ADME Sciences (QTAS), AbbVie Inc; 9. Quantitative Clinical Pharmacology, Daiichi Sankyo Inc; 10. Pharmacokinetics and Drug Metabolism DepartmentShow moreShow less
79
days
Extracellular vesicles as xenobiotic-metabolizing enzyme carriers: a new paradigm for brain drug metabolism
Authors
Veena V Tom; Ann Mary Jose; Athira Sasidharan; Yogish Somayaji; Ronald FernandesShow moreShow less
Affiliations
1. Department of Allied Health Sciences, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS); 2. Department of Post Graduate Studies and Research in Biochemistry, St. Aloysius (Deemed to be University); 3. Department of Biochemistry and Biophysics, Texas A&M University; 4. Department of Pharmaceutical Chemistry, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS)Show moreShow less
26
days
Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy
Authors
Mostafa K. Abd El-Aziz; Ali H. Shalaby; Sara R. El-Mahrouk; Ayman O. S. El-KadiShow moreShow less
Affiliations
1. Faculty of Pharmacy and Pharmaceutical Sciences, University of AlbertaShow moreShow less
83
days
Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review
Authors
Tahir Saleem; Muhammad Fawad Rasool; Hamid Saeed; Faleh AlqahtaniShow moreShow less
Affiliations
1. Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University; 2. University College of Pharmacy, Allama Iqbal Campus, University of the Punjab; 3. Department of Pharmacology and Toxicology, College of Pharmacy, King Saud UniversityShow moreShow less
113
days
A review on analytical perspectives for cyclophosphamide, its metabolites, and impurities
Authors
Harshal Ahirrao; Hemant Kumar Tatapudi; Kishore Raju VatsavaiShow moreShow less
Affiliations
1. Department of Pharmaceutical Quality Assurance, School of Pharmacy & Technology Management, SVKMs NMIMS; 2. Veranova LPShow moreShow less
77
days
Redox enzyme networks shaping cancer drug metabolism and therapeutic resistance
Authors
Başak Gökçe; Şeyma Rana KarakaşShow moreShow less
Affiliations
1. Department of Biochemistry, Faculty of Pharmacy, Suleyman Demirel University; 2. Faculty of Pharmacy, Suleyman Demirel UniversityShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
